Meredith B. Long, Ph.D. - Publications
Affiliations: | 2001 | Duke University, Durham, NC |
Area:
Molecular Biology, Medicine and SurgeryYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Long SB, Long MB, White RR, Sullenger BA. Crystal structure of an RNA aptamer bound to thrombin. Rna (New York, N.Y.). 14: 2504-12. PMID 18971322 DOI: 10.1261/Rna.1239308 | 0.571 | |||
2004 | Kierlin MN, Byun J, Lan N, Long M, Sullenger B. 903. Group I Ribozymes and SMaRT|[trade]| as Trans-Splicing RNA Repair Therapies for |[beta]|-Globin Mutations Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.809 | 0.626 | |||
2003 | Byun J, Lan N, Long M, Sullenger BA. Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes. Rna (New York, N.Y.). 9: 1254-63. PMID 13130139 DOI: 10.1261/Rna.5450203 | 0.62 | |||
2003 | Long MB, Jones JP, Sullenger BA, Byun J. Ribozyme-mediated revision of RNA and DNA. The Journal of Clinical Investigation. 112: 312-8. PMID 12897196 DOI: 10.1172/Jci19386 | 0.651 | |||
2000 | Guo H, Karberg M, Long M, Jones JP, Sullenger B, Lambowitz AM. Group II introns designed to insert into therapeutically relevant DNA target sites in human cells. Science (New York, N.Y.). 289: 452-7. PMID 10903206 DOI: 10.1126/Science.289.5478.452 | 0.579 | |||
1999 | Long MB, Sullenger BA. Evaluating group I intron catalytic efficiency in mammalian cells. Molecular and Cellular Biology. 19: 6479-87. PMID 10490588 DOI: 10.1128/Mcb.19.10.6479 | 0.625 | |||
Show low-probability matches. |